Cleerly
Latest round
- Series C
Last raised
- Nov 2024
Total raised
- $314M
Investors
- 16
About Cleerly
Founded in 2016 and based in New York, US, Cleerly, Inc. develops an AI-integrated digital platform that provides helpful insights and evaluations that help in preventing coronary artery disease. The company was formed from the research efforts of The Dalio Institute for Cardiovascular Imaging at the New York-Presbyterian Hospital and Weill Cornell Medicine, which later turned into Cleerly's technological progress. It was founded by Dr. James K. Min. In November 2024, Cleerly, Inc. The company's product is an AI-integrated platform and solution that uses non-invasive AI-driven FDA-cleared technologies to identify the plaques that might cause coronary artery disease. For health professionals, the solution provides image analysis and data to help and support clinical diagnosis, prognostication, and the decision-making process. The platform also provides helpful insights to patients in order for them to understand the factors and prevention of coronary artery disease. The company's revenue is generated by the sales of its AI-integrated solution offered for imaging physicians, clinicians, and patients.
Who invested in Cleerly
16 investors across 3 rounds
See all investors in Cleerly
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cleerly
Who invested in Cleerly?
Cleerly has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cleerly raised?
Cleerly has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cleerly last raise money?
Cleerly's most recent round on record is a Series C, in Nov 2024.
What does Cleerly do?
Founded in 2016 and based in New York, US, Cleerly, Inc.
Where is Cleerly headquartered?
Cleerly is headquartered in Denver, US.
Which VCs invest in companies like Cleerly?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Cleerly's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like Cleerly? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.